Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors, which have been known to play a role in inflammation in many organs, including the brain.

14 Feb 2019

Discovery of a 'master switch' within the immune system

Researchers Professor Graham Lord, from The University of Manchester and colleagues have found that a specific part of the immune system could have the tools that may help in the therapy of some major diseases such as diabetes, cancer, multiple sclerosis, Crohn’s disease and other autoimmune diseases.

14 Feb 2019

Study identifies protein regulator that induces Th17 cells to cause multiple sclerosis

Inflammatory and autoimmune diseases such as psoriasis, rheumatoid arthritis, and multiple sclerosis (MS) are a major healthcare burden worldwide and are life-altering conditions for afflicted patients.

14 Feb 2019

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

Cell membrane complexes may be new target for drugs to kill cancer cells

Old molecules and new complexes: researchers at Hollings Cancer Center at the Medical University of South Carolina have discovered cell membrane complexes called ceramidosomes that may be a new target for drugs to kill cancer cells.

13 Feb 2019

Blood-clotting factor may cause Alzheimer's disease

A protein known for its role in forming blood clots has been found to cause the characteristic cognitive decline of Alzheimer's disease.

7 Feb 2019

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

It was not the centerpiece, but health was a persistent theme in President Donald Trump's State of the Union address at the Capitol on Tuesday night.

6 Feb 2019

Fibrinogen results in cognitive decline in Alzheimer’s disease, finds study

It has long been known that patients with Alzheimer's disease have abnormalities in the vast network of blood vessels in the brain. Some of these alterations may also contribute to age-related cognitive decline in people without dementia.

6 Feb 2019

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

Following a California Institute for Regenerative Medicine Independent Citizens Oversight Committee meeting held last week, University of California, Irvine researchers learned they will receive $6 million in funding to support the continued development of a promising new treatment for Huntington's disease

5 Feb 2019

RhoE protein plays key role in the development of nervous system

Researchers have revealed the key role of the RhoE protein in essential processes for the development of the central nervous system, such as myelination.

3 Feb 2019

Researchers compare treatment options for fecal incontinence

It is a common health problem that causes uncommon personal discomfort. Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence.

29 Jan 2019

Researcher identifies putative mechanism that leads to degeneration of axons in multiple sclerosis

The permanent neurological deficits of multiple sclerosis patients largely depend on the extent of degeneration of long nerve fibers. The latter is initiated by ruptures in the cell membrane and the resulting influx of calcium ions.

25 Jan 2019

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

La Jolla Institute for Immunology has been awarded a $22 million contract renewal over seven years from the National Institutes of Health to host and expand the Immune Epitope Database.

24 Jan 2019

New insights into brain cell types of people with MS could help develop improved therapies

Fresh insights into the types of cells found in the brains of people with multiple sclerosis could help develop improved therapies, research has found.

24 Jan 2019

Myelin-producing cells are altered in multiple sclerosis, shows study

Subpopulations of oligodendrocytes, myelin-producing cells in the brain that are targeted by the immune system in multiple sclerosis (MS), are altered in MS and might therefore have additional roles in the disease than previously described.

23 Jan 2019

Old oligodendrocytes can repair damage in the brains of patients with multiple sclerosis

A new study shows that there is a very limited regeneration of cells in the brain of patients diagnosed with multiple sclerosis.

23 Jan 2019

Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath

Diseases such as multiple sclerosis are characterized by damage to the 'myelin sheath', a protective covering wrapped around nerve cells akin to insulation around an electrical wire.

22 Jan 2019

Simple blood test reliably detects signs of Alzheimer’s damage before symptoms

A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease - even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany.

21 Jan 2019

FSU study provides better understanding of spinal cord injuries

Thousands of people worldwide suffer severe spinal cord injuries each year, but little is known about why these injuries often continue to deteriorate long after the initial damage occurs.

21 Jan 2019

Multiple sclerosis therapies delay progression of disability

An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important.

17 Jan 2019

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

Discovery of a 'master switch' within the immune system

Study identifies protein regulator that induces Th17 cells to cause multiple sclerosis

Keynote speakers announced for CBD Expo MIDWEST

Cell membrane complexes may be new target for drugs to kill cancer cells

Blood-clotting factor may cause Alzheimer's disease

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

Fibrinogen results in cognitive decline in Alzheimer’s disease, finds study

CIRM announces funding for UCI researchers to develop new treatment for Huntington’s disease

RhoE protein plays key role in the development of nervous system

Researchers compare treatment options for fecal incontinence

Researcher identifies putative mechanism that leads to degeneration of axons in multiple sclerosis

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

New insights into brain cell types of people with MS could help develop improved therapies

Myelin-producing cells are altered in multiple sclerosis, shows study

Old oligodendrocytes can repair damage in the brains of patients with multiple sclerosis

Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath

Simple blood test reliably detects signs of Alzheimer’s damage before symptoms

FSU study provides better understanding of spinal cord injuries

Multiple sclerosis therapies delay progression of disability

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in